SRA and its binding partners: An expanding role for RNA-binding coregulators in nuclear receptor-mediated gene regulation SRA and its binding partners S. M. Colley and P. J. Leedman

Critical Reviews in Biochemistry and Molecular Biology

Volumn 44, Issue 1, 2009, Pages 25-33

  Colley, Shane M ^a   Leedman, Peter J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Coregulators; Nuclear receptor; RNA binding proteins; SLIRP; SRA

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID RECEPTOR; MYOD PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE RECEPTOR; PROTEIN P68; PROTEIN P72; REGULATOR PROTEIN; REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR; RNA BINDING PROTEIN; SMRT HDAC1 ASSOCIATED REPRESSOR PROTEIN; STEM LOOP INTERACTING RNA BINDING PROTEIN; STEROID RECEPTOR RNA ACTIVATOR; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; C14ORF156 PROTEIN, HUMAN; CELL RECEPTOR; UNTRANSLATED RNA;

CARCINOGENESIS; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, UNTRANSLATED; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 65649114746     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.1080/10409230802661719     Document Type: Review

References (55)

1. Auboeuf D, Dowhan DH, Li X, Larkin K, Ko L, Berget SM, and O?Malley BW. 2004. CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing. Mol Cell Biol 24:442-453.
2. Brent GA. 1994. Te molecular basis of thyroid hormone action. New England Journal of Medicine 331:847-853.
3. Bykhovskaya Y, Casas K, Mengesha E, Inbal A, and Fischel-Ghodsian N. 2004. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303-1308.
4. Caretti G, Schiltz RL, Dilworth FJ, Di Padova M, Zhao P, Ogryzko V, Fuller-Pace FV, Hofman EP, Tapscott SJ, and Sartorelli V. 2006. Te RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle diferentiation. Dev Cell 11:547-560.
5. Caretti G, Lei EP, and Sartorelli V. 2007. Te DEAD-box p68/p72 proteins and the noncoding RNA steroid receptor activator SRA: eclectic regulators of disparate biological functions. Cell Cycle 6:1172-1176.
6. Cavarretta IT, Mukopadhyay R, Lonard DM, Cowsert LM, Bennett CF, O?Malley BW, and Smith CL. 2002. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation. Mol Endocrinol 16:253-270.
7. Chooniedass-Kothari S, Emberley E, Hamedani MK, Troup S, Wang X, Czosnek A, Hube F, Mutawe M, Watson PH, and Leygue E. 2004. Te steroid receptor RNA activator is the frst functional RNA encoding a protein. FEBS Lett 566:43-47.
8. Chooniedass-Kothari S, Hamedani MK, Troup S, Hube F, and Leygue E. 2006. Te steroid receptor RNA activator protein is expressed in breast tumor tissues. Int J Cancer 118:1054-1059.
9. Coleman KM, Lam V, Jaber BM, Lanz RB, and Smith CLK. 2004. SRA coactivation of estrogen receptor-alpha is phosphorylation-independent, and enhances 4-hydroxytamoxifen agonist activity. Biochem Biophys Res Commun 323:332-338.
10. Deblois G, and Giguere V. 2003. Ligand-independent coactivation of ERalpha AF-1 by steroid receptor RNA activator (SRA) via MAPK activation. J Steroid Biochem Mol Biol 85:123-131.
11. Dowhan DH, Hong EP, Auboeuf D, Dennis AP, Wilson MM, Berget SM, and O?Malley BW. 2005. Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERalpha and CAPERbeta. Mol Cell 17:429-439.
12. Emberley E, Huang GJ, Hamedani MK, Czosnek A, Ali D, Grolla A, Lu B, Watson PH, Murphy LC, and Leygue E. 2003. Identifcation of new human coding steroid receptor RNA activator isoforms. Biochem Biophys Res Commun 301:509-515.
13. Hatchell EC, Colley SM, Beveridge DJ, Epis MR, Stuart LM, Giles KM, Redfern AD, Miles LE, Barker A, MacDonald LM, Arthur PG, Lui JC, Golding JL, McCulloch RK, Metcalf CB, Wilce JA, Wilce MC, Lanz RB, O?Malley BW, Leedman PJ. Mol Cell. 2006 Jun 9; 22(5):657-668
14. Hube F, Guo J, Chooniedass-Kothari S, Cooper C, Hamedani MK, Dibrov AA, Blanchard AA, Wang X, Deng G, Myal Y, and Leygue E. 2006. Alternative splicing of the frst intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA Cell Biol 25:418-428.
15. Hussein-Fikret S, and Fuller PJ. 2005. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours. Mol Cell Endocrinol 229:149-160.
16. Iwasaki T, Chin WW, and Ko L. 2001. Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM). J Biol Chem 276:33375-33383.
17. Katze MG, Wambach M, Wong ML, Garfnkel M, Meurs E, Chong K, Williams BR, Hovanessian AG, and Barber GN. 1991. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system. Mol Cell Biol 11:5497-5505.
18. Kawashima H, Takano H, Sugita S, Takahara Y, Sugimura K, and Nakatani T. 2003. A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. Biochem J 369:163-171.
19. Kitamura A, Nishizuka M, Tominaga K, Tsuchiya T, Nishihara T, and Imagawa M. 2001. Expression of p68 RNA helicase is closely related to the early stage of adipocyte differentiation of mouse 3T3-L1 cells. Biochem Biophys Res Commun 287:435-439.
20. Lalli E, and Sassone-Corsi P. 2003. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual diferentiation. Mol Endocrinol 17:1445-1453.
21. Lalli E, Ohe K, Hindelang C, and Sassone-Corsi P. 2000. Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Mol Cell Biol 20:4910-4921.
22. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ, and O?Malley BW. 1999. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97:17-27.
23. Lanz RB, Razani B, Goldberg AD, and O?Malley BW. 2002. Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA). Proc Natl Acad Sci USA 99:16081-16086.
24. Lanz RB, Chua SS, Barron N, Soder BM, DeMayo F, and O?Malley BW. 2003. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol 23:7163-7176.
25. Leygue E. 2007. Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer. Nucl Recept Signal 5:e006.
26. Leygue E, Dotzlaw H, Watson PH, and Murphy LC. 1999. Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res 59:4190-4193.
27. Lonard DM, Lanz RB, and O?Malley BW. 2007. Nuclear receptor coregulators and human disease. Endocr Rev 28:575-587.
28. McKenna NJ, and O?Malley BW. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474.
29. Meggio F, and Pinna LA. 2003. One-thousand-and-one substrates of protein kinase CK2? Faseb J 17:349-368.
30. Monsalve M, Wu Z, Adelmant G, Puigserver P, Fan M, and Spiegelman BM. 2000. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol Cell 6:307-316.
31. Morrish F, Buroker NE, Ge M, Ning XH, Lopez-Guisa J, Hockenbery D, and Portman MA. 2006. Tyroid hormone receptor isoforms localize to cardiac mitochondrial matrix with potential for binding to receptor elements on mtDNA. Mitochondrion 6:143-148.
32. Murphy LC, Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A, and Watson PH. 2000. Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Res 60:6266-6271.
33. Nettles KW, and Greene GL. 2005. Ligand control of coregulator recruitment to nuclear receptors. Annu Rev Physiol 67:309-333.
34. Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM, and Schif R. 2003. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/ neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 95:353-361.
35. Patton JR, Bykhovskaya Y, Mengesha E, Bertolotto C, and Fischel-Ghodsian N. 2005. Mitochondrial myopathy and sideroblastic anemia (MLASA): missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation. J Biol Chem 280:19823-19828.
36. Pedram A, Razandi M, Wallace DC, Levin ER. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell. 2006 May; 17(5):2125-2137
37. Powelka AM, Seth A, Virbasius JV, Kiskinis E, Nicoloro SM, Guilherme A, Tang X, Straubhaar J, Cherniack AD, Parker MG, and Czech MP. 2006. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest 116:125-136.
38. Robyr D, Wolfe AP, and Wahli W. 2000. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 14:329-347.
39. Roeder RG. 2005. Transcriptional regulation and the role of diverse coactivators in animal cells. FEBS Lett 579:909-915.
40. Seth A, Steel JH, Nichol D, Pocock V, Kumaran MK, Fritah A, Mobberley M, Ryder TA, Rowlerson A, Scott J, Poutanen M, White R, Parker M. Te transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab. 2007 Sep; 6(3):236-245
41. Shi Y, Downes M, Xie W, Kao HY, Ordentlich P, Tsai CC, Hon M, and Evans RM. 2001. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev 15:1140-1151.
42. Sionov RV, Cohen O, Kfr S, Zilberman Y, and Yefenof E. 2006. Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. J Exp Med 203:189-201.
43. Smith CL, and O?Malley BW. 2004. Coregulator function: a key to understanding tissue specifcity of selective receptor modulators. Endocr Rev 25:45-71.
44. Stevens M, De Clercq E, and Balzarini J. 2006. Te regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention. Med Res Rev 26:595-625.
45. Torres-Arzayus MI, Font de Mora J, Yuan J, Vazquez F, Bronson R, Rue M, Sellers WR, and Brown M. 2004. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice defne AIB1 as an oncogene. Cancer Cell 6:263-274.
46. Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, Suzawa M, Kobayashi Y, Yano T, Yoshikawa H, Masuhiro Y, Kato S. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.
47. Westin S, Rosenfeld MG, and Glass CK. 2000 Embo J 20:1341-1352.
48. Nuclear receptor coactivators. Adv Pharmacol 47: 89-112.
49. Xu B, and Koenig RJ. 2004. An RNA-binding domain in the thyroid hormone receptor enhances transcriptional activation. J Biol Chem 279:33051-33056.
50. Xu B, and Koenig RJW. 2005. Regulation of thyroid hormone receptor alpha2 RNA binding and subcellular localization by phosphorylation. Mol Cell Endocrinol 245:147-157.
51. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, and O?Malley BW. 2000. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 97:6379-6384.
52. Yang M. 2005. Discoveries of Tat-TAR interaction inhibitors for HIV-1. Curr Drug Targets Infect Disord 5:433-444.
53. Zhao X, Patton JR, Davis SL, Florence B, Ames SJ, and Spanjaard RA. 2004. Regulation of nuclear receptor activity by a pseudouridine synthase through posttranscriptional modification of steroid receptor RNA activator. Mol Cell 15:549-558.
54. Zhao X, Patton JR, Ghosh SK, Fischel-Ghodsian N, Shen L, and Spanjaard RA. 2007. Pus3p- and Pus1p-dependent pseudouridylation of steroid receptor RNA activator controls a functional switch that regulates nuclear receptor signaling. Mol Endocrinol 21:686-699.
55. Zhu Y, Qi C, Cao WQ, Yeldandi AV, Rao MS, and Reddy JK. 2001. Cloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function. Proc Natl Acad Sci USA 98:10380-10385.